Listed

Allogene Therapeutics, Inc.

ALLONasdaqCIK 1737287HealthcareFiscal year ends Dec 31

Reports and events: 139 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Allogene Therapeutics, Inc., Reports and events
FiledFormWhat it isAccession number
2023-11-0216:03 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001737287-23-000089
2023-10-1716:34 ET8-K/A5.02 Departure or appointment of officers or directors0001737287-23-000083
2023-10-1608:31 ET8-K5.02 Departure or appointment of officers or directors0001737287-23-000079
2023-08-0216:07 ET10-QQuarterly reportPeriod 2023-06-300001737287-23-000076
2023-08-0216:04 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001737287-23-000074
2023-06-2116:05 ET8-K8.01 Other events0001737287-23-000067
2023-06-1516:08 ET8-K5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001737287-23-000063
2023-06-1408:04 ET8-K5.02 Departure or appointment of officers or directors0001737287-23-000060
2023-06-0716:16 ET8-K8.01 Other events0001737287-23-000056
2023-05-0316:09 ET10-QQuarterly reportPeriod 2023-03-310001737287-23-000053
2023-05-0316:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001737287-23-000051
2023-04-2416:06 ETDEF 14AProxy statement0001737287-23-000041
2023-04-2016:08 ET8-K5.02 Departure or appointment of officers or directors0001737287-23-000028
2023-03-1016:00 ET8-K7.01 Regulation FD disclosure0001737287-23-000023
2023-02-2816:12 ET10-KAnnual reportPeriod 2022-12-310001737287-23-000018
2023-02-2816:07 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001737287-23-000017
2023-01-0308:05 ET8-K5.02 Departure or appointment of officers or directors0001737287-23-000003
2022-11-2915:33 ET8-K8.01 Other events0001737287-22-000089
2022-11-0216:22 ET10-QQuarterly reportPeriod 2022-09-300001737287-22-000083
2022-11-0216:16 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001737287-22-000081
2022-10-0616:20 ET8-K8.01 Other events0001737287-22-000074
2022-09-2109:05 ET8-K8.01 Other events0001737287-22-000072
2022-08-0916:13 ET10-QQuarterly reportPeriod 2022-06-300001737287-22-000067
2022-08-0916:07 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001737287-22-000065
2022-07-1216:05 ET8-K5.02 Departure or appointment of officers or directors0001737287-22-000049
2022-06-1716:16 ET8-K5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001737287-22-000039
2022-05-0416:19 ET10-QQuarterly reportPeriod 2022-03-310001737287-22-000035
2022-05-0416:09 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001737287-22-000033
2022-04-2616:28 ETDEF 14AProxy statementPeriod 2022-06-150001737287-22-000026
2022-02-2316:11 ET10-KAnnual reportPeriod 2021-12-310001737287-22-000013
2022-02-2316:08 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001737287-22-000012
2022-01-1816:50 ETSC 13D/AOwnership report, active investor, amended0001387131-22-000412
2021-12-1510:09 ET8-K1.01 Entry into a material agreement; 8.01 Other events0001737287-21-000054
2021-11-0416:20 ET10-QQuarterly reportPeriod 2021-09-300001737287-21-000051
2021-11-0416:13 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001737287-21-000049
2021-10-0716:20 ET8-K8.01 Other events0001737287-21-000042
2021-08-0416:42 ET10-QQuarterly reportPeriod 2021-06-300001737287-21-000040
2021-08-0416:37 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001737287-21-000039
2021-08-0216:29 ET8-K5.02 Departure or appointment of officers or directors0001737287-21-000034
2021-06-1516:01 ET8-K5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001737287-21-000030
2021-05-2017:20 ET8-K5.02 Departure or appointment of officers or directors0001737287-21-000027
2021-05-1917:04 ET8-K8.01 Other events0001737287-21-000025
2021-05-0516:24 ET10-QQuarterly reportPeriod 2021-03-310001737287-21-000022
2021-05-0516:20 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001737287-21-000021
2021-04-2216:27 ETDEF 14AProxy statementPeriod 2021-06-100001737287-21-000013
2021-02-2516:57 ET10-KAnnual reportPeriod 2020-12-310001737287-21-000009
2021-02-2516:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001737287-21-000007
2020-12-1508:32 ET8-K1.01 Entry into a material agreement0001737287-20-000064
2020-12-0708:31 ET8-K8.01 Other events0001737287-20-000061
2020-11-0408:00 ET10-QQuarterly reportPeriod 2020-09-300001737287-20-000059

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 10, 2026, 16:34 ET. Listed shows no prices and gives no investment advice.